Journal of Medical Virology

Papers
(The H4-Index of Journal of Medical Virology is 61. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Effect of the coronavirus pandemic on tumor markers654
Epidemiology and genetic characterization of human metapneumovirus in pediatric patients from Hangzhou China414
Current immunoassays and detection of antibodies elicited by Omicron SARS‐CoV‐2 infection407
Aggregation of high‐frequency RBD mutations of SARS‐CoV‐2 with three VOCs did not cause significant antigenic drift370
Human monkeypox outbreak in 2022310
On the SARS‐CoV‐2 BA.2.75 variant: A genetic and structural point of view281
Diversity of human sapovirus genotypes detected in Japanese pediatric patients with acute gastroenteritis, 2014–2017229
A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID‐19 (SARS‐CoV‐2) pandemic224
Factors associated with dexamethasone efficacy in COVID‐19. A retrospective investigative cohort study220
Associations of human papillomavirus (HPV) genotypes and related risk factors in a cohort of women living with HIV in a Brazilian countryside city210
Novel SARS‐CoV‐2 entry inhibitors, 2‐anilinoquinazolin‐4(3H)‐one derivatives, show potency as SARS‐CoV‐2 antivirals in a human ACE2 transgenic mouse model187
Back Cover Image, Volume 95, Number 6, June 2023183
Relationship between SARS‐CoV‐2 vaccination and cases, program breakthrough cases, and deaths in Dois Vizinhos, Paraná, Brazil176
Maximal temperature varies by sex and ethnic group in hospital in‐patients with Covid‐19 infection174
Comment on Higashimoto et al. “Analysis of the reliability of rapid diagnostic tests for varicella, including breakthrough cases”167
165
Antiviral therapy in DRESS157
Clinical observation of neutralizing antibody DXP‐604 for treatment critical COVID‐19 patients infected with SARS‐CoV‐2 Delta variant156
Rates and Factors Related to COVID‐19 Vaccine Uptake in Racialized and Indigenous Individuals in Canada: The Deleterious Effect of Experience of Racial Discrimination153
Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and Cardiovascular Outcomes in People Living With Chronic Hepatitis B130
Low Neutralization of SARS‐CoV‐2 Omicron BA5248, XBB15 and JN1 by Homologous Booster and Breakthrough Infection129
Wild‐Type and rtA181T/sW172* Mutant Strains of Hepatitis B Virus Drive Hepatocarcinogenesis via Distinct GRP78‐Mediated ER Stress Pathways126
Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID‐19123
Vaccination hesitancy and the “myth” on mRNA‐based vaccines in Italy in the COVID‐19 era: Does urgency meet major safety criteria?118
Strong association of functional polymorphism in IL‐12B with susceptibility to chronic hepatitis B in Tunisia112
Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID‐19 patients102
Evaluation of the late presentation and associated factors of people living with HIV in Turkey102
The relationship between liver pathological inflammation degree and pyroptosis in chronic hepatitis B patients102
Gut microbiota dysbiosis is associated with sepsis‐induced cardiomyopathy in patients: A case‒control study101
Ultrarapid and ultrasensitive detection of SARS‐CoV‐2 antibodies in COVID‐19 patients via a 3D‐printed nanomaterial‐based biosensing platform99
Does ACE2 mediate the detrimental effect of exposures related to COVID‐19 risk: A Mendelian randomization investigation97
Mutations in SARS‐CoV‐2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure96
Genetic variability analysis of human papillomavirus 58: Novel sublineage identification and persistent infection association95
Posttranslational modifications of ACE2 protein: Implications for SARS‐CoV‐2 infection and beyond95
A case of congenital human cytomegalovirus infection with placental and pulmonary calcification despite presence of intrauterine IgG94
Cytological features of human papillomavirus‐infected immature squamous metaplastic cells from cervical intraepithelial neoplasia grade 293
Neutralizing antibody PR8‐23 targets the footprint of the sialoglycan receptor binding site of H1N1 hemagglutinin90
Human monkeypox (hMPXV) re‐emergence: Host immunity status and current vaccines landscape89
Cocirculation and coinfection of multiple respiratory viruses during autumn and winter seasons of 2023 in Beijing, China: A retrospective study83
Adenovirus F41 infection and liver cytolysis in adult hematopoietic stem cell transplant recipients82
COVID‐19 vaccination and decreased death rates: A county‐level study in Pennsylvania80
Exploring the dynamics of the 2022 mpox outbreak in Canada79
Real‐world effectiveness of Azvudine versus nirmatrelvir‐ritonavir in hospitalized patients with COVID‐1978
mRNA‐HPV vaccine encoding E6 and E7 improves therapeutic potential for HPV‐mediated cancers via subcutaneous immunization75
5‐Nitrobenzo[c][1, 2, 5]selenadiazole as therapeutic agents in the regulation of oxidative stress and inflammation induced by influenza A(H1N1)pdm09 in vitro and in vivo73
Examination of control asymptomatic cohorts reveals heightened anti‐EBV and HHV‐6 A/B dUTPase antibodies in the aging populations72
New‐onset type 1 diabetes in children and adolescents as postacute sequelae of SARS‐CoV‐2 infection: A systematic review and meta‐analysis of cohort studies72
MORC3 restricts human cytomegalovirus infection by suppressing the major immediate‐early promoter activity71
Associated microbiota and treatment of severe fever with thrombocytopenia syndrome complicated with infections70
Distribution of cervical intraepithelial neoplasia is closely associated with HPV status and uterine position68
On the severity of COVID‐19 infections in 2021 in Italy68
Herpes simplex virus and SLE: Though uncommon yet with significant implications67
Establishment of nucleic acid sensing pathways‐based model in predicting response to immunotherapy and targeted drug in hepatitis virus‐related hepatocellular carcinoma67
Efficacy and safety of current treatment interventions for patients with severe COVID‐19 infection: A network meta‐analysis of randomized controlled trials65
Exploring the mechanisms of long COVID: Insights from computational analysis of SARS‐CoV‐2 gene expression and symptom associations65
Characterization of antibody‐dependent cellular phagocytosis in patients infected with hepatitis C virus with different clinical outcomes64
First wave of COVID‐19 in Venezuela: Epidemiological, clinical, and paraclinical characteristics of first cases63
Lack of monkeypox virus (MPXV) transmission despite occupational exposure of a large number of health care workers63
SARS‐CoV‐2 NSP12 utilizes various host splicing factors for replication and splicing regulation63
A novel three‐plasmid packaging system for chimeric SFV/SIN VRPs derived from Semliki Forest virus and Sindbis virus as a candidate gene delivery vector62
Inspiratory muscle training for COVID‐19: Benefits appear promising but findings remain uncertain62
Performance and feasibility of universal PCR admission screening for SARS‐CoV‐2 in a German tertiary care hospital61
One dose versus two doses of COVID‐19 vaccine for the prevention of breakthrough infections among people previously infected with SARS‐Cov‐261
A specific natural killer cells phenotypic signature associated to long term elite control of HIV infection61
Sequencing on an imported case in China of COVID‐19 Delta variant emerging from India in a cargo ship in Zhoushan, China61
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV61
Nobel calling Harald zur Hausen61
0.082128047943115